Glenis Willmott MEP, Labour MEP for the East Midlands and Labour's European spokesperson on health, today received the Award for Outstanding Leadership from the Belgian Association of Clinical Researchers.
The award recognises Ms Willmott's extensive work on encouraging medical research and ensuring full transparency of clinical trial results.
Glenis Willmott MEP said:
“I am thrilled to be receiving this award from the experts in medical research. Three years ago, I visited a brain tumour centre in Nottingham where I met children suffering from some of the rarest cancers. For some of these children a clinical trial might be their only hope of survival.
"But because the conditions are so rare, researchers needed to work across borders and conduct a trial in a number of different countries at the same time. Currently that is very difficult and extremely expensive, but the new EU rules I have negotiated should facilitate those life-saving cross-border trials.”
Currently the results of only half of all trials are published, which can lead to unnecessary or even dangerous research being repeated. It can also lead to bad decision-making around health, as demonstrated recently by the stockpiling of billions of pounds worth of flu medicines, which previously unpublished trial results had shown were not particularly effective.
Glenis Willmott MEP added:
"These new rules will mean the results of trials must be published, advancing science and ensuring patient safety."
"I hope these rules will encourage more research in the UK, and a more transparent system for pharmaceuticals across the whole of Europe."